Skip to main content
SpringerLink
Log in
Book cover

Positron Emission Tomography with Computed Tomography (PET/CT) pp 91–102Cite as

Missed in PET

  • Chapter
  • First Online:

  • 2022 Accesses

Abstract

PET/CT for the purpose of cancer screening may give false positive findings which may cause undue worry and false negative findings which may give a false sense of security.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chang JM, Lee HJ, Goo JM, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7(1):57–69.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ghotbi N, Iwanaga M, Ohtsuru A, et al. Cancer screening with whole-body PET/CT for healthy asymptomatic people in Japan: re-evaluation of its test validity and radiation exposure. Asian Pac J Cancer Prev. 2007;8(1):93–7.

    PubMed  Google Scholar 

  3. Masciari S, Van den Abbeele AD, Diller LR, et al. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008;299(11):1315–9.

    Article  CAS  PubMed  Google Scholar 

  4. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. F-18 fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712–20.

    Article  PubMed  Google Scholar 

  5. Schoder H, et al. F-18 FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47:755–62.

    PubMed  Google Scholar 

  6. Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074–8.

    Article  PubMed  Google Scholar 

  7. Sohn YN, Kwak JY, Kim EK, et al. Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. AJR Am J Roentgenol. 2010;194(1):38–43.

    Article  PubMed  Google Scholar 

  8. Palmedo H, Bucerius J, Joe A, et al. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med. 2006;47:616–24.

    PubMed  Google Scholar 

  9. Epstein DM. Bronchioloalveolar carcinoma: a review. Semin Roentgenol. 1990;25:105–11.

    Article  CAS  PubMed  Google Scholar 

  10. Higashi K, Ueda Y, Seki H, et al. Fluorine -18 FDG-PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998;39:1016–20.

    CAS  PubMed  Google Scholar 

  11. Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest. 1993;104:997–1002.

    Article  CAS  PubMed  Google Scholar 

  12. Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchoalveolar carcinoma? Eur J Nucl Med. 2002;29:1166–73.

    Article  CAS  Google Scholar 

  13. Goudarzi B, Jacene HA, Wahl RL. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. J Nucl Med. 2008;49:1585–92.

    Article  PubMed  Google Scholar 

  14. Miyakita H, Tokunaga M, Yasuda S. Significance of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol. 2002;9:15–8.

    Article  PubMed  Google Scholar 

  15. Oyama N, Okazawa H, Kusukawa N, et al. C-11 acetate PET imaging for renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:422–7.

    Article  PubMed  Google Scholar 

  16. Nakatani K, Nakamoto Y, Suga T, et al. Clinical value of FDG-PET for recurrent renal cell carcinoma [abstract]. J Nucl Med. 2009;50(Supp 2):461.

    Google Scholar 

  17. Huang B-K, Chu Y-K. Isometabolic renal cell carcinoma on 18F-FDG PET:a case report. Ann Nucl Med Sci. 2010;23:153–7.

    Google Scholar 

  18. Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol. 2008;179(1):34–45.

    Article  CAS  PubMed  Google Scholar 

  19. Salminen E, Hogg A, Binns D, Frydenberg M, Hicks R. Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta Oncol. 2002;41(5):425–9.

    Article  PubMed  Google Scholar 

  20. Oyama N, Akino H, Suzuki Y, et al. Increased accumulation of F-18 FDG in untreated prostate cancer. Jpn J Clin Oncol. 1999;29:623–9.

    Article  CAS  PubMed  Google Scholar 

  21. Chang C, Wu H, Tsai J, Shen Y, Changlai S, Kao A. Detecting metastastic pelvic lymph nodes by 18F-2-deoxy-glucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer. Urology. 2003;70:311.

    Google Scholar 

  22. Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004;45(1):19–27.

    Article  PubMed  Google Scholar 

  23. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.

    Article  PubMed  Google Scholar 

  24. Cuaron J, Dunphy M, Rimner A. Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer. Front Oncol. 2013. doi:10.3389/fonc.2012.00208.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and PET Center, St. Luke’s Medical Center, Taguig City, MM, Philippines

    Jonas Francisco Y. Santiago

Authors
  1. Jonas Francisco Y. Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Santiago, J.F.Y. (2015). Missed in PET. In: Positron Emission Tomography with Computed Tomography (PET/CT). Springer, Cham. https://doi.org/10.1007/978-3-319-05518-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-05518-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-05517-6

  • Online ISBN: 978-3-319-05518-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation